AHA26: Lilly’s Foundayo benefits beyond weight loss in Phase III sleep apnoea win
Lilly’s Foundayo gained approval in the US in January 2026 for weight loss and has since been approved in the EU for the same patients.
10 November 2026
10 November 2026
Lilly’s Foundayo gained approval in the US in January 2026 for weight loss and has since been approved in the EU for the same patients.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.